ATHYRIUM CAPITAL MANAGEMENT LP

Thesis

Athyrium Capital Management is a specialized asset management company focused on global investment opportunities within the healthcare sector. The firm advises funds with over $4.6 billion of committed capital. Athyrium invests across all healthcare verticals, including pharmaceuticals, biotechnology, healthcare services, healthcare technology, and medical devices and products. Athyrium invests in a wide range of financial instruments, including royalties, structured credit, and equities, as well as select special situations. They focus on commercial-stage companies with compelling products and differentiated services, industry-leading management teams, and multi-year commitments with the opportunity to upsize over time. Athyrium has a global investment mandate, investing in companies located in North America, Europe, Asia, and Australia. Athyrium provides debt and structured financing, including term loans, senior secured loans, note purchase agreements, credit facilities, and royalty-backed debt to healthcare companies. They also make equity and growth investments across multiple fund vintages (Fund I–IV) into biotech, pharma, healthcare services, healthcare technology, and equipment companies.

Related lists

• Series C+ investors based in New York, NY